Top 50 Medical Device VC Funds & Investors in Italy (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
CDP Venture Capital
VC Fund
|
8 | Italy, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $488k–$17M |
|
Panakes Partners
VC Fund
|
6 | Italy, Switzerland, United Kingdom | Series B, Series A, Series C | Health Care, Medical, Medical Device | $3.3M–$110M |
|
Italian Angels for Growth
VC Fund
|
6 | Italy, United States, United Kingdom | Seed, Angel, Series A | Software, E-Commerce, Health Care | $219k–$11M |
|
Principia SGR
VC Fund
|
5 | Italy, United States, United Kingdom | Series A, Seed | Health Care, Biotechnology, Software | $329k–$7.7M |
|
Innogest Capital
VC Fund
|
4 | Italy, United States, Spain | Series A, Series B | Health Care, Medical, Medical Device | $1.1M–$29M |
|
A11 Venture
VC Fund
|
4 | Italy, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical Device, E-Commerce | $384k–$1.4M |
|
EUREKA! Venture SGR
VC Fund
|
3 | Italy | Seed, Pre-Seed | Nanotechnology, Manufacturing, Medical Device | $384k–$4.1M |
|
Club degli Investitori
VC Fund
|
3 | Italy, Switzerland, United Kingdom | Seed, Series A | Health Care, E-Commerce, Information Technology | $197k–$19M |
|
Bios Line Holding
VC Fund
|
2 | Italy | Seed | Sports, Leisure, E-Commerce | $549k–$1.3M |
|
Healthware Ventures
VC Fund
|
2 | Italy, Austria, United States | Seed, Pre-Seed, Series A | Health Care, Personal Health, PaaS | $823k–$1.9M |
|
ENEA Tech e Biomedical
VC Fund
|
2 | Italy, Finland | Series A, Venture - Series Unknown | Health Care, Biotechnology, Medical Device | $3.3M–$21M |
|
Intesa Sanpaolo
VC Fund
|
2 | Italy, United Kingdom, United States | Debt Financing, Post-IPO Debt, Convertible Note | Energy, Financial Services, Renewable Energy | $299k–$2.5B |
|
Italian Angels for Biotech
VC Fund
|
2 | Italy | Seed | Health Care, Biotechnology, Pharmaceutical | $549k–$2M |
|
Vertis
VC Fund
|
2 | Italy, United States, United Kingdom | Seed, Series A | Software, Computer, E-Commerce | $823k–$10M |
|
LIFTT
VC Fund
|
2 | Italy, United Kingdom, France | Seed, Series A | Software, Biotechnology, Manufacturing | $329k–$21M |
|
UniCredit
VC Fund
|
2 | Italy, Germany, Spain | Debt Financing, Post-IPO Debt, Seed | Manufacturing, Energy, Renewable Energy | $384k–$1.1B |
|
Invitalia Ventures
VC Fund
|
2 | Italy, United States, United Kingdom | Series A, Seed | Software, Medical, Internet | $658k–$6.2M |
|
Simon Fiduciaria
VC Fund
|
1 | Italy, United Kingdom | Seed, Series B | Therapeutics, Simulation, Biotechnology | |
|
SIMEST
VC Fund
|
1 | Italy | Grant, Series A, Series B | Manufacturing, Coffee, Aerospace | |
|
50 Partners Health
VC Fund
|
1 | ||||
|
Estor
VC Fund
|
1 | Italy | Seed | Health Care, Biotechnology, Medical Device | |
|
Sefea Impact
VC Fund
|
1 | Italy | Medical, Health Care, Medical Device | ||
|
Manilo Marocco Partners
VC Fund
|
1 | Italy | Series A | Wellness, Psychology, Health Care | |
|
Rancilio Cube
VC Fund
|
1 | United States, Italy, Germany | Seed, Series A, Series B | E-Commerce, Software, Financial Services | |
|
Capital Cell
VC Fund
|
1 | Spain, United States, United Kingdom | Equity Crowdfunding, Seed | Health Care, Biotechnology, Medical | |
|
I.A.C.E.R. srl
VC Fund
|
1 | Italy | Seed | Wellness, Health Care, Medical Device | |
|
Cysero
VC Fund
|
1 | Italy | Seed | Mobile, Internet, Robotics | $2.1M–$5.5M |
|
INGENIUM Emilia Romagna
VC Fund
|
1 | Italy | Seed, Angel | Medical, Health Care, Privacy | $2.1M–$2.2M |
|
Equiter
VC Fund
|
1 | Italy | Seed, Series B, Convertible Note | Medical, Health Care, Information Technology | $2.2M–$3.8M |
|
Atlante Ventures
VC Fund
|
1 | Italy, United States, Israel | Seed, Series A | Software, Biotechnology, Hardware | $150k–$3.5M |
|
Green Arrow Capital
VC Fund
|
1 | Italy, United Kingdom | Seed, Series A | Health Care, Biotechnology, Manufacturing | $1.5M–$2.2M |
|
Global Payments SpA
VC Fund
|
1 | Italy | Seed | FinTech, Wearables, Biometrics | |
|
Fountain Healthcare Partners
VC Fund
|
1 | Ireland, United States, France | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $3.3M–$110M |
|
F3F
VC Fund
|
1 | Italy | Series A, Series B, Series C | Hardware, Hospital, Software | $3.3M–$9.2M |
|
Sistema Investimenti
VC Fund
|
1 | Italy | Seed | Mobile, Medical, Health Care | $500k–$2.1M |
|
Spindial Group
VC Fund
|
1 | Italy | Medical, Health Care, Biotechnology | ||
|
Lazio Innova
VC Fund
|
1 | Italy, United Kingdom | Seed, Pre-Seed, Grant | Software, Health Care, Artificial Intelligence | $27k–$1.9M |
|
Fondazione Golinelli
VC Fund
|
1 | Italy | Seed, Pre-Seed | FinTech, Financial Services, AgTech | $122k–$467k |
|
Roca X
VC Fund
|
1 | Romania, Italy, Israel | Seed, Pre-Seed, Convertible Note | Software, Information Technology, Health Care | $55k–$2M |
|
Amazon Alexa Fund
VC Fund
|
1 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning | $120k–$120M |
|
Toscana Next Fund
VC Fund
|
1 | Italy | Seed, Series A | Manufacturing, Robotics, Electronics | $1.6M–$5.8M |
|
Deep Blue Ventures
VC Fund
|
1 | Italy | Seed, Venture - Series Unknown | E-Learning, Biotechnology, Medical Device | $2M–$2.2M |
|
Omnes Capital
VC Fund
|
1 | France, Germany, United States | Series A, Series B | Software, Biotechnology, Health Care | $3.5M–$43M |
|
Indaco Venture Partners
VC Fund
|
1 | Italy, Switzerland, United States | Series A, Series B | Biotechnology, Health Care, Life Science | $1.5M–$52M |
|
Embed Capital
VC Fund
|
1 | Italy, Switzerland, United Kingdom | Seed, Pre-Seed | Information Technology, Mobile, Health Care | $132k–$2.1M |
|
EISMEA
VC Fund
|
1 | Spain, Switzerland, United Kingdom | Grant, Seed | Biotechnology, Software, Health Care | $55k–$2.7M |
|
GM&C Life Sciences Fund
VC Fund
|
1 | United Kingdom, Italy, Germany | Seed, Series A | Health Care, Biotechnology, Medical | $65k–$4.1M |
|
Andera Partners
VC Fund
|
1 | France, United States, Germany | Series B, Private Equity | Biotechnology, Health Care, Medical | $14M–$247M |
|
Fondazione Cottino
VC Fund
|
1 | Italy | Seed | Medical, mHealth, Diabetes | |
|
Sviluppo Imprese Centro Italia
VC Fund
|
1 | Italy | Seed, Angel, Pre-Seed | Software, Travel, Medical | |
| Access all 98 VC funds in Italy Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 228
- Round size: Seed $488k–$8.3M; Series A $3.3M–$17M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $197M in 2021
Portfolio highlights
- Radical Storage — Find your closest luggage storage and enjoy your journey until the very end!
- Mela Works — Manage your work site with Mela, and generate logbooks and reports with one click. Download Mela now!
- Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series B, Series A, Series C
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 40
- Round size: Series A $3.3M–$31M; Series B $9.9M–$60M; Series C $18M–$110M
- Lead/follow: 53% lead, 47% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- EBAMed — EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware andsoftware components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients.
- Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 100
- Round size: Seed $329k–$4.6M; Angel $219k–$1.2M; Series A $2.7M–$11M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Cato AI — Cato AI is a Milan-based B2B SaaS startup that uses AI to automate public tender management.
- Fitprime — Il Partner unico per il Wellbeing Aziendale
- Alomana —
Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 50
- Round size: Seed $329k–$3.3M; Series A $1.5M–$7.7M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $187M in 2014
Portfolio highlights
- KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B
- Geography: Italy, United States, Spain
Investor stats
- Total investments: 68
- Round size: Series A $1.1M–$11M; Series B $2.7M–$29M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $99M in 2015
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Prestiamoci — Prestiamoci is the first community of loans between individuals born in Italy, allowing you to make profitable investment and to obtain loans with installments transparent.With Prestiamoci the providers invest and get Claimants, returning to its original role of the bank safe. Loans shall be paid by people to trustworthy people who want toachieve their life projects, grow their professional activity, better manage expenses and major purchases
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
A11-Venture investe nel capitale di startup innovative nei settori della robotica, automazione, meccatronica, cleantech, web e IT. Facilita la nascita e lo sviluppo di business innovativi globali per il futuro dell'economia locale. Contribuisce a costruire aziende, lavoro qualificato, brevetti, innovazione capaci di rilanciare e riportareinvestimenti e risorse sul territorio. I soci di A11 Venture credono fermamente nell’innovazione grazie a ciò è possibile crescere per linee esterne diversificando i propri investimenti, grazie ad un portafoglio di imprese, con una forte risk mitigation derivante dalla gestione professionale di tutti processi: scouting, team building, investimenti, management degli investimenti, accelerazione e disinvestimento.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United States
Investor stats
- Total investments: 13
- Round size: Seed $384k–$1.4M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Reefilla — Reefilla EV charging services: recharge your car anywhere, anytime
- Endostart — Endostart development and manufacturing of a new generation medical devices for gastrointestinal endoscopy.
- Neuron Guard — Neuron Guard, recognized as the best European startup in HEALTH category (Startup Europe Awards - SEUA 2017), is developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. Every 7 seconds around the world a person suffers of Acute Brain Damage because of CardiovascularDiseases (CVD) and Traumatic Brain Injury (TBI). They are the most costly and prevalent killers in the last 15 years (15 million deaths by CVD in 2015), and the leading cause of disability (the global incidence rate of TBI is 200 per 100k people per year). WHO estimated a global expenditure of $ 330 billion in 2015, but it is going to increase sharply: $ 4 trillion in 2025 - including premature death, disability, and health care costs - just for CVD in LMICs. Temperature is a vital body parameter. It regulates all cellular functions so its management is essential for the good outcome of patients in several medical conditions such as cardiac arrest, stroke, traumatic brain injury, neuro and cardiac surgery, epilepsy, migraine and oncology. Regulating body temperature at a desired level makes all other treatments more effective. The most modern medical approach is the target temperature management, where physicians try to maintain the most favourable temperature for the patient for up to 24-36 hours, preventing excessive warming (fever) or cooling.Our device is a targeted temperature management system composed by a THERAPEUTIC COLLAR POWERED BY A SMART CONTROL UNIT (the size of a small briefcase). The collar transforms the neck into a natural heat exchanger exploiting several physiological and anatomical characteristics of the human body. It is quicker to act on brain tissue but can also function as total body temperature adjusting device if required. A disposable protective shield makes cleaning the collar after each use simple while featuring an optimal safety profile both in term of pathogens and allergens. The control unit collects all the data of the treatment and transmits them to the Emergency Response System. Our mission is to improve the safety of patients on the roadside, at home or in the workplace, and to reduce the costs of chronic care. In fact, Neuron Guard aims to be the only device that can be used in every circumstance, inside and outside the hospital, and allow the user to fully manage the temperature of the patient warming and cooling as necessary. Our vision is to have a Neuron Guard kit in every public place just like the Automatic External Defibrillator (AED) to empower bystanders to immediately react in case of emergency. Under this perspective our device becomes a connected-intelligent platform that takes care of the patient, connects the scene with the Emergency Response System transmitting vital data to improve the readiness and effectiveness of professional intervention.The device is patented in Italy, USA and China. We have made several prototypes in collaboration with Italian and English companies, such as Tecno Elettra Impianti and TWI, tested it in laboratory and published the experimental results on the NeuroCritical Care Journal. We have also conducted a GAP Analysis with another English consulting firm (CDP) and we are testing the human prototype internally. We are seeking to raise 2.5M€ to complete the pre-industrialization, with design and construction of the human device for the pilot trial, finalized the regulatory clearance and launch it into the market in 2019.
Eureka! is the first independent Italian venture capital Asset Management company exclusively focused on deep tech investments
Show more...Investment focus
- Industry: Nanotechnology, Manufacturing, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 31
- Round size: Seed $384k–$4.1M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- FLEEPtech — FLEEP Technologies designs and develops printed electronics solutions for the biomedical and smart packaging sectors. The company, spin-off of Istituto Italiano di Tecnologia, was founded in May 2019.FLEEPtech developed a proprietary process for the fabrication of polymer-based integrated circuits based on Organic Thin-Film Transistors, creatingthe intelligent core for electronics systems that are mechanically flexible, printed like magazines and recyclable. FLEEPtech is the missing link in the printed electronics industry between a great number of flexible and printed products (i.e. sensors, actuators and energy supplies) that find little space in being integrated with standard non-flexible electronics. For such reasons, the company's mission revolves around the realization of a general purpose platform for the manufacturing of fully-printed integrated systems, composed by printed sensors, printed actuators, printed energy supplies and harvesters and, of course, printed integrated circuits.
- INTA Systems — Nanotech and artificial intelligence for biomolecular analysis
- Alter Eco Pulp — Alter Eco Pulp is a fiber molding company that processes waste and natural cellulose fibers to manufacture disposable products.
Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.
Show more...Investment focus
- Industry: Health Care, E-Commerce, Information Technology
- Stage:Seed, Series A
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 94
- Round size: Seed $197k–$7.6M; Series A $889k–$19M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Largix — Largix is the first company to develop and commercially produce 3D Robotic Printers for real production processes. We have invented the "Cold 3D Printing®" technology that makes 3DP possible for real industrial production. Largix uses the most common thermoplastic polymers: Polypropylene and Polyethylene, polymers that nobody else iscapable of printing.
- Spacest.com By Roomless — Rent directly online with Roomless, the safe and simple platform for those looking for a house for rent.
- Approxima — Approxima medical is developing a novel treatment for patients with tricuspid valve regurgitation
investment firm
Show more...Investment focus
- Industry: Sports, Leisure, E-Commerce
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 3
- Round size: Seed $549k–$1.3M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- Freedome — Freedome is the leading marketplace for outdoor activities in Italy
Healthware Ventures is the corporate venture capital arm of Healthware Group
Show more...Investment focus
- Industry: Health Care, Personal Health, PaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, Austria, United States
Investor stats
- Total investments: 7
- Round size: Seed $823k–$1.9M; Pre-Seed $1M–$1.3M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- PatchAi — Improve patient engagement and experience in clinical trials and standard care. Discover Patchai solution.
- 1000Farmacie — 1000Farmacie is the leading Pharmacy Marketplace in Italy. Though a network of independent Pharmacies we deliver faster!
- YourCoach Health — Health and Wellness coach practice management solution enabling coaches to holistically lead their clients, connecting mind, body and soul through behavior modification and accountability tools towards outcomes
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Venture - Series Unknown
- Geography: Italy, Finland
Investor stats
- Total investments: 12
- Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $8.4M–$21M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
Intesa Sanpaolo is a banking group that specializes in wealth management, protection, advisory, and digital orientation. Their products and services include accounts, cards, loans, mortgages, insurance, digital payments, retirement planning, investments, and consulting. It was founded by the merger of Banca Intesa and Sanpaolo IMI.
Show more...Investment focus
- Industry: Energy, Financial Services, Renewable Energy
- Stage:Debt Financing, Post-IPO Debt, Convertible Note
- Geography: Italy, United Kingdom, United States
Investor stats
- Total investments: 122
- Round size: Post-IPO Debt $112M–$2.5B; Debt Financing $878k–$1.1B; Convertible Note $299k–$2.2M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- NextGeo —
- Goglio Group — Goglio Group produces full trademark food packaging.
- EuroGroup Laminations — We develop and produce stators and rotors solutions for the energy transition, guaranteeing maximum efficiency and sustainability on a global scale.
Angel group focuses on biotech
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 4
- Round size: Seed $549k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
- Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
Vertis is a dynamic and independent investment management company authorised by Bank of Italy. It manages five closed-end funds for qualified investors by participating in research projects, spin-offs, startups and PMI and deals with the investments of the innovative Made in Italy.
Show more...Investment focus
- Industry: Software, Computer, E-Commerce
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 62
- Round size: Seed $823k–$3.6M; Series A $1.5M–$10M
- Lead/follow: 58% lead, 42% follow
- Last fund: Likely still investing — raised $35M in 2021
Portfolio highlights
- Tuidi — Tuidi is a tech startup that develops predictive models of AI, with a particular focus on the food distribution sector. They combine methodical study of data, personalization of business processes and speed of integration for to return an output that is not only accurate but also free from interpretation difficulties so as to increase profits,reduce stock outages and optimize inventories.
- Focoos AI — Focoos reshapes computer vision with ultra-efficient models that drive down costs, automate hardware integration, and ensure peak performance on any device, while promoting sustainability.
- TimeFlow — TimeFlow is a software that acts as a B2B marketplace dedicated to the technical and managerial consulting sector.
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Seed, Series A
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 69
- Round size: Seed $329k–$4.7M; Series A $2.7M–$21M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
- Maieutical Labs — I Maieutical Labs sono un insieme di piattaforme ispirate al Mastery Learning, immersive e mobile-oriented, dedicate allo studio nella scuola secondaria
- Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
UniCredit is a pan-European commercial bank offering unique banking services in Italy, Germany, Central and Eastern Europe.
Show more...Investment focus
- Industry: Manufacturing, Energy, Renewable Energy
- Stage:Debt Financing, Post-IPO Debt, Seed
- Geography: Italy, Germany, Spain
Investor stats
- Total investments: 100
- Round size: Seed $384k–$15M; Post-IPO Debt $40M–$1.1B; Debt Financing $417k–$614M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- FITT — FITT specializes in thermoplastic fluid transfer and management solutions.
- EuroGroup Laminations — We develop and produce stators and rotors solutions for the energy transition, guaranteeing maximum efficiency and sustainability on a global scale.
- E4 Computer Engineering — E4 Computer Engineering stands out for its tireless pursuit of the most cutting edge proposals in the IT sector.
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more...Investment focus
- Industry: Software, Medical, Internet
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 30
- Round size: Seed $658k–$1.6M; Series A $900k–$6.2M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — raised $89M in 2017
Portfolio highlights
- Ecomate — The ESG Rating platform for every company
- BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
- Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
Simon Fiduciaria nasce nel 1986 per prestare servizi fiduciari a importanti gruppi familiari, imprenditori e professionisti, a livello nazionale ed estero.
Show more...Investment focus
- Industry: Therapeutics, Simulation, Biotechnology
- Stage:Seed, Series B
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
- Annaida Technologies — Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance (“µNMR”) at a scale 10-fold better than existing technologies.
SIMEST is a financial firm focused on the development and promotion of Italian enterprises abroad. Simest acquires up to 49% of the equity capital of foreign firms in countries outside the European Union, whether wholly-owned by Italian companies or set up as joint ventures with local partners. It also provides start-up and growth capital financingas well as participating in buyouts.Geographically it invests in non-EU countries, focusing on BRIC, Americas and Middle-East. Simest also provides Italian companies seeking to internationalize their businesses with technical assistance and advisory services.Simest is a member of the European Development Finance Institutions (EDFI) and the Italian Venture Capital and Private Equity Association (AIFI).
Show more...Investment focus
- Industry: Manufacturing, Coffee, Aerospace
- Stage:Grant, Series A, Series B
- Geography: Italy
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- hlpy — hlpy operates as a roadside assistance company. Hlpy provides a digital roadside assistance service via a network of 580+ centers, 1,900+ drivers/mechanics, 2,800+ tow trucks.
- Objectway — Powered by over 30 years of business expertise in delivering wealth and asset management technology and services, Objectway empowers its clients to embrace their future challenges while providing great performance today.Objectway solutions and services enable opti-channel customer engagement, front-office productivity, stronger investmentperformance, suitable advice and compliance enforcement, efficient back-office operations and automation, pro-active client reporting and management analytics.Our front-to-back, multi-channel, scalable, cloud-ready platform leverages a component-based architecture with AI-driven algorithmic engines for risk & performance analytics, real-time investment compliance, portfolios optimisation and mass customisation, with open APIs for easy integration.Objectway is a Global Top 100 fintech provider (IDC ranking) and our clients include 200+ leading wealth managers, banks, asset managers, fund managers, insurers and outsourcing providers in more than 15 countries. We support approximately 100,000 investment professionals to manage more than £1 trillion in assets.Objectway operates from offices in Italy, UK, Ireland and Belgium serving customers in 4 continents.
- BionIT Labs — We apply IT to Bionics in order to Turn disabilities into New Possibilities
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Medicud — Medicud develops a device for treating wounds with negative pressure dressing.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Estor is a Investment Firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Endostart — Endostart development and manufacturing of a new generation medical devices for gastrointestinal endoscopy.
Sefea Impact is an asset management company that setting up and managing closed-end alternative investment funds. It aims to generate social impacts through fundamental tools such as tailored finance, technical assistance, and impact measurement.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- BionIT Labs — We apply IT to Bionics in order to Turn disabilities into New Possibilities
Manilo Marocco Partners is an investment firm.
Show more...Investment focus
- Industry: Wellness, Psychology, Health Care
- Stage:Series A
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Restorative Neurotechnologies — Siamo un'azienda di dispositivi medicali certificati per la riabilitazione cognitiva ed il trattamento di disturbi cognitivi post ictus.
Cube is the investment office founded by Rancilio family
Show more...Investment focus
- Industry: E-Commerce, Software, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Italy, Germany
Investor stats
- Total investments: 66
- Lead/follow: no public data
Portfolio highlights
- Convoy — Using technology and automation, the Convoy Platform seamlessly connects carriers with shipments from brokers across the nation.
- FinCompare - Smarter Business Finance — FinCompare was founded by Stephan Heller and is a fintech startup that helps businesses to find, compare, and close the financing solutions. Via the online platform, companies can access a wide range of financing options. They can independently compare offers from well-known banks, fintechs, and alternative financial services providers in Germanyand close the financing. The company also offers a convenient one-stop destination for all financing questions relating to the company.FinCompare financing solutions including corporate loan, factoring, company leasing/hire purchase, warehouse financing, fine trading/purchase financing, and mezzanine capital. It simplifies the financing process with its digital application process and can thus provide your company financing. The company allows SMEs to receive and compare various offers for loans.FinCompare was founded in October 2016 by Stephan Heller and is headquartered in Berlin, Germany.
- Finom — Finom is an online payment solution for entrepreneurs that makes it easy to open a business account and securely manage their finances.
Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Equity Crowdfunding, Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 47
- Lead/follow: no public data
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- OxyPrem — OxyPrem is a Swiss manufacturer of next-generation medical devices for oxygen-related brain monitoring of preterm infants in real time, using harmless, non-invasive near-infrared light. Our sensors continuously measure local oxygenation with the precision and accuracy that are needed to assist in clinical decision-making for these high-risk patients.
- MSInsight — Explore how our cutting-edge genomic analysis uncovers actionable insights into microsatellite instability (MSI), driving targeted, personalized cancer treatments.
Manufacturer of medical devices for home rehabilitation
Show more...Investment focus
- Industry: Wellness, Health Care, Medical Device
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Euleria Health — Devices and technologies for more accessible and measurable rehabilitation and telerehabilitation at the service of clinics and movement experts, in the clinic and at home.
Cysero is a venture capital fund focused on the robotics and cybersecurity sectors. The fund was established in October 2020 and managed by AVM Gestioni SGR S.p.A. Manager EuVECA Società Benefit and jointly promoted with Kilometro Rosso, Bergamo's science and technology park.
Show more...Investment focus
- Industry: Mobile, Internet, Robotics
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 7
- Round size: Seed $2.1M–$5.5M
- Lead/follow: 86% lead, 14% follow
Portfolio highlights
- Octostar — Octostar is the AI-powered investigative intelligence platform for law enforcement, national security, and financial institutions. Connect the dots and discover the facts across petabytes of data.
- TrueScreen — Certify photo, video, screenshot, document and audio recording with legal value. Prevent fraud and disputes obtaining indisputable evidences
- Next Generation Robotics — Next Generation Robotics is a company that manufactures robotic systems for inspection and monitoring for the railway industry.
INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
Show more...Investment focus
- Industry: Medical, Health Care, Privacy
- Stage:Seed, Angel
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $2.1M–$2.2M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Equiter seleziona, realizza e gestisce investimenti infrastrutturali in capitale di rischio finalizzati allo sviluppo socio-economico del territorio.
Show more...Investment focus
- Industry: Medical, Health Care, Information Technology
- Stage:Seed, Series B, Convertible Note
- Geography: Italy
Investor stats
- Total investments: 6
- Round size: Seed $2.2M–$3.8M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- AWorld — AWorld is The Sustainability Platform and Mobile App chosen by the United Nations to support the ActNow Campaign.
- Medics — 3D anatomical modeling per la pianificazione pre-operatoria e il supporto intra-operatorio delle chirurgie complesse.
- Faccin Group — Faccin Group leads in manufacturing top tier metal forming & bending machines. Operating as Faccin, Roundo & Boldrini, we offer unparalleled expertise.
Atlante Ventures is a leading Italian VC fund, operated by IMI Fondi Chiusi SGR, part of Intesa Sanpaolo Group.
Show more...Investment focus
- Industry: Software, Biotechnology, Hardware
- Stage:Seed, Series A
- Geography: Italy, United States, Israel
Investor stats
- Total investments: 46
- Round size: Seed $150k–$3.5M; Series A $1.5M–$3.3M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — last raise in 2007
Portfolio highlights
- ADmantX — A NEW ERA OF AUDIENCE TARGETINGADmantX is a contextual analysis and data provider that brings audience targeting to a new level. Awarded patent for semantic advertising technology, the company offers a cookie-less solution that allows publishers, ad networks and exchanges, brand managers and agencies to develop more effective online adcampaigns leveraging semantic understanding, natural language processing and sentiment analysis. Founded in Italy as a spin-off of the leading semantic company Expert System, ADmantX is active in Europe and US. Worldwide customers include NBCUniversal, Integral Ad Science, Networked Insights, Banzai, Cadreon, Amnet, Sojern, Media IQ and ADmantX solutions are integrated in key DSP players such as Turn, Adform and AppNexus.
- YOGITECH — Notizie e approfondimenti di Tecnologia
- Expert.ai — Expert.ai is the premier artificial intelligence platform for language understanding.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Green Arrow Capital is an independent financial group specializing in alternative investments across Europe. They represent a one-of-a-kind platform, capable of connecting the financial system with the real economy through the management of private equity, private debt, infrastructure, and special credit situation funds as well as thematic fundssuch as microfinance and funds of funds that are currently under management. Their team has a successful track record in asset management, investment banking, industry sectors, technology startups, management consulting, renewable energy, and has government and regulatory experience. Their group is mainly composed of investment, asset management, and financial advisory companies. Their aim is to create a solid financial platform to launch and manage investment funds dedicated to alternatives and to the real economy.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Seed, Series A
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 9
- Round size: Series A $1.5M–$2.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Directa Plus — Directa Plus is a nanotechnology company, manufactures nanoparticles.
- Maticmind S.p.A — Maticmind S.p.A is a company that provides ICT and system integration solutions to telecommunications operators.
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Global Payments SpA is a wholly-owned subsidiary of TAS Group.
Show more...Investment focus
- Industry: FinTech, Wearables, Biometrics
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Flywallet — Flywallet founded by Lorenzo Frollini at the end of 2018 together to Arianna Ludovica Frollini, Matteo Egidi e Alessandro Massimiani, is an innovative startup that connects payment, mobility and health services by enclosing them in a single ecosystem and putting safety first, thanks to biometrics and proprietary wearable and IoT technologies. Ithas created Keyble, a new type of wearable that adapts to the user's lifestyle, created with eco-sustainable materials and inspired by made-in-Italy fashion. It consists in a smart module which can be inserted into fashion accessories such as bracelets or watch straps and is equipped with biometric sensors for user authentication and to monitor their health. Through the fingerprint or heartbeat via ECG, the user enables payments in stores, passwordless access to online services, ticketing for public transport, loyalty cards, access to gyms, offices and homes, car door locks and digital identity. In Q1 2022, the wearable will reach the certification for medical device for performing the analysis of cardiac arrhythmias, blood oxygen saturation and body temperature. Flywallet offers a unique model of "Biometric Wearable Platform as Service" aimed to electronic money and payment institutions, banks, insurance companies and firms. The Flywallet Platform includes the world's 1st wallet for tokenizing payment cards on wearables equipped with biometric authentication and allows Partner companies to deliver new types of services through API connection in a simple and secure way.
Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: Ireland, United States, France
Investor stats
- Total investments: 49
- Round size: Series A $6.6M–$44M; Series B $5.5M–$68M; Series C $3.3M–$110M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $128M in 2019
Portfolio highlights
- Mainstay Medical — Mainstay Medical is improving quality of life for patients with chronic low back pain through innovative restorative treatment medical device solutions.
- Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
- XyloCor Therapeutics — XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease. The company's service focuses on developing gene therapy to stimulate the formation of new coronary blood vessels and serve areas of the heart that are not receiving adequate blood supply, enabling patientswith refractory angina who exhausted pharmacologic options to cure their cardiovascular diseases painlessly and cost effectively.
F3F
Show more...Investment focus
- Industry: Hardware, Hospital, Software
- Stage:Series A, Series B, Series C
- Geography: Italy
Investor stats
- Total investments: 4
- Round size: Series A $3.3M–$9.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Sistema Investimenti is an holding in the form of SpA, established by the will of young professionals and entrepreneurs in Sicily. Sistema Investimenti focus on qualified minorities primarily in companies in the South of Italy with the exception of turnaround/restructuring and distressed.
Show more...Investment focus
- Industry: Mobile, Medical, Health Care
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 2
- Round size: Seed $500k–$2.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pedius — Pedius is a communication system that allows deaf people to make normal phone calls. Use it in your everyday life to make important calls such as booking doctors appointments or making reservations, or to call family, friends and coworkers.Once you download the smartphone app you can start a conversation by either typing or speaking a message.The recipient will listen on their end and reply, and you will immediately read a transcription of what he or she just said. Pedius gives you the freedom to have real-time conversations when you need to call a plumber, book a table at your favourite restaurant, or talk to your doctor.The Pedius app is especially useful when you need to contact someone accessible only by phone, and it is an excellent help when you need to be careful about your privacy.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Spindial Group
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Grant
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 20
- Round size: Seed $186k–$1.9M; Grant $27k–$33k; Pre-Seed $53k–$549k
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- Joinrs — Cut the noise. Joinrs uses AI to find the jobs that actually match your skills, experience and preferences. Over 2 million job seekers trust Joinrs.
- Medicud — Medicud develops a device for treating wounds with negative pressure dressing.
- Ticketoo — Compra e vendi biglietti in modo etico su Ticketoo. La piattaforma sicura per transazioni fan-to-fan. Trova i migliori eventi e assicurati il biglietto per i tuoi spettacoli preferiti.
Fondazione Golinelli was born in Bologna in 1988 by the will of the entrepreneur and philanthropist Marino Golinelli with the aim to promote education and training, to promote the culture, to foster intellectual growth and ethics of young people, the citizens of tomorrow.
Show more...Investment focus
- Industry: FinTech, Financial Services, AgTech
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $122k–$467k
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Biorfarm — Adotta il tuo Albero, crea il tuo Campo Digitale e ricevi a domicilio la tua frutta biologica. Solo con Biorfarm puoi seguire la crescita dei tuoi frutti!
- EvenFi — Criptalia uses blockchain technology to connect businesses that have projects to be funded with people and organizations who are looking for high-yield investments. We offer an online platform where companies publish their innovative ideas and industrial improvement projects. Investors, people, and institutions can fund these projects by lendingmoney in exchange for a higher interest rate.
- Latitudo40 — Empower sustainable growth with AI-driven satellite insights from Latitudo 40. Unlock precise, real-time data for smarter urban planning, climate risk management, and industry innovation. Enhance resilience and lead with confidence.
RocaX > Is building a solid and much needed bridge for startups between the support offered by business angels and the upper stage VCs. Learn more!
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Romania, Italy, Israel
Investor stats
- Total investments: 31
- Round size: Seed $150k–$2M; Pre-Seed $55k–$878k; Convertible Note $165k–$1.1M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $4.7M in 2019
Portfolio highlights
- iFactor — iFactor is an online portal that helps to sell their invoices for immediate cash and asset protofolio with a low-risk investments for SMEs.
- Bonapp.eco — bonapp.eco is a mobile application that connects consumers with traders whose food is approaching its expiry date to combat food wastage.
- Bunnyshell — Bunnyshell is a a simple and fast cloud-agnostic DevOps automation platform to deploy, scale, and optimize your applications.We provide easy infrastructure management on multiple clouds , application management and DevOps Tools.Bunnyshell increases speed, performance, and scalability & works on the most popular major clouds: AWS, DigitalOcean, Azure, Linode, Vultr, UpCloud.Our platform allows you to focus on growing your app, while we take care of the rest: real time monitoring, auto scaling, smart self-healing servers, one click deployment. Backed by 24/7 real time support.
The Amazon Alexa Fund is Amazon’s venture capital fund investing in artificial intelligence, frontier tech, voice, robotics, and digital health across consumer and enterprise. We invest in early- to growth-stage companies globally. To learn more, visit us at alexafund.com.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 137
- Round size: Seed $120k–$5.9M; Series A $5.1M–$46M; Series B $11M–$120M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $100M in 2017
Portfolio highlights
- Endel — Personalized soundscapes to help you focus, relax, and sleep. Backed by neuroscience.
- Hearvana — Hearvana is a IT consulting company.
- Yousician — Yousician is a fun way to learn the guitar, piano, bass, ukulele or singing. Enjoy thousands of songs with Yousician as your personal music teacher!
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Toscana Next Fund is a co-investment fund managed by CDP Venture Capital.
Show more...Investment focus
- Industry: Manufacturing, Robotics, Electronics
- Stage:Seed, Series A
- Geography: Italy
Investor stats
- Total investments: 7
- Round size: Seed $1.6M–$1.9M; Series A $4.9M–$5.8M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Small Pixels — SmallPixels provides video and image from compressed video streams applicable to movies, TV series, surveillance videos, and video chats to users, delivering an experience with reduced streaming expenses.
- Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
- Next Generation Robotics — Next Generation Robotics is a company that manufactures robotic systems for inspection and monitoring for the railway industry.
DEEP BLUE VENTURES Venture Capital Fund DEEP BLUE VENTURES DBV Deep Blue Ventures is our first Venture Capital fund DBV is an early stage deep tech fund, investing in outstanding deep technologies, and people able to harnessing them to great global success. Deep Blue Ventures
Show more...Investment focus
- Industry: E-Learning, Biotechnology, Medical Device
- Stage:Seed, Venture - Series Unknown
- Geography: Italy
Investor stats
- Total investments: 3
- Round size: Seed $2M–$2.2M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- AI4IV — AI4IV is a start-up developing and marketing revolutionary bio-inspired vision sensor technology, combing the advantages of neuromorphic devices with those of digital CMOS devices. No other technologies currently available provide this unique combination or are based on similar concepts.Our vision sensor technology has already been validated withsilicon prototypes. We now aim at making available camera chips that can acquire images without artifacts even in the most challenging light conditions and extract the relevant information from the scene with an innovative on-die integrated AI processor.Our target use cases include autonomous vehicles, machine vision, robotics, security & surveillance and agriculture.
- UpSurgeOn — The UpSurgeOn Academy is a hi-tech sequence of virtual and physical technologies designed to support Mental and Manual training and empower cognitive and psychomotor skills of any surgeon.
- INTA Systems — Nanotech and artificial intelligence for biomolecular analysis
Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Series A, Series B
- Geography: France, Germany, United States
Investor stats
- Total investments: 173
- Round size: Series A $3.5M–$37M; Series B $4.4M–$43M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $403M in 2020
Portfolio highlights
- VSORA — VSORA provides high performance companion solutions combining AI and signal processing to enable autonomous driving and ADAS
- Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
- Amakem — Easy, affordable options for you to obtain the domain you want. Safe and secure shopping.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B
- Geography: Italy, Switzerland, United States
Investor stats
- Total investments: 42
- Round size: Series A $1.5M–$31M; Series B $8.8M–$52M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- CamGraPhIC — Our platform supports the ever-increasing data traffic demand with high-performing and low-power consumption electro-optical engines.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Embed Capital directly invests in startups, established or in the process of creation.Embed is mainly focused on innovative companies that:- Are active in the so-called “real economy” sectors: industrials, technology, environment, services, retail or social;- Are characterized by simple and intuitive business models and valuepropositions, and operate in markets or market segments featuring high growth potential;- Present a clear competitive advantage and high barriers-to-entry;- Are cash-generative in the medium term.Given that Embed Capital is not a closed-end fund, it doesn’t have specific time-constrains and it can assess on a project-by-project basis to determine the best time to sell a participation, and sign customized agreements with the entrepreneurs.
Show more...Investment focus
- Industry: Information Technology, Mobile, Health Care
- Stage:Seed, Pre-Seed
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $132k–$2.1M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Piantando — Piantando sells plants connected to initiatives for the preservation of the planet engaged in the following areas: land, water, climate, biodiversity and local communities. Each plant is equivalent to a transparent and unique contribution, destined to an initiative certified by our Value Chain. Everyone become ambassadors of a new way of livinggreen and understanding their commitment to the planet.
- FrescoFrigo - Healthy food close to you — FrescoFRIGO is a smart fridge with fresh and quality products designed for the needs of worker. Improve everyday lifestyle, through automated proximity selling of good, fresh and healthy product, innovating technology and user experience.
- The Nemesis — The Nemesis is the playground for play-to-earn games and adventures in virtual worlds. Accessible on both mobile and desktop.
Executive Agency for SMEs
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed
- Geography: Spain, Switzerland, United Kingdom
Investor stats
- Total investments: 176
- Round size: Seed $55k–$2.2M; Grant $55k–$2.7M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
- Cyclomics — Discover Cyclomics, pioneers in precision cancer diagnostics using breakthrough consensus-sequencing paired with the Nanopore platform. Our innovative solutions enable ultra-sensitive detection of cancer mutations directly from blood samples, transforming the future of liquid biopsy. Learn more about how Cyclomics is revolutionizing early cancer detection, monitoring, and personalized treatment with cutting-edge, accessible molecular diagnostics.
- Terraplasma — As pioneers in cold plasma science, our team of scientists, engineers, and experts have played a key role in driving research and commercial development. Our groundbreaking work has brought cold plasma technology to companies, public institutions and even private households worldwide.
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Italy, Germany
Investor stats
- Total investments: 33
- Round size: Seed $65k–$936k; Series A $1.8M–$4.1M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Maxwellia — A contraceptive pill, Lovima, is now available to buy without a prescription.
- Acea Health — Acea Health is a digital healthcare company developing an application called Flynotes - a new digital consent platform. Flynotes analyses a number of factors, including the patient’s background, to deliver personalised risks and benefits. Flynotes aims to be the go-to solution for consent in healthcare. .
- Nexus Labs (Surgical Teaching) — Nexus Labs is an interactive learning resource for medical students.
Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Private Equity
- Geography: France, United States, Germany
Investor stats
- Total investments: 177
- Round size: Series B $14M–$85M; Private Equity $110M–$247M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $466M in 2022
Portfolio highlights
- MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
- Amolyt Pharma — AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
- ImCheck Therapeutics — ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.
Fondazione Cottino is support young people in their educational path and support for scientific research, technology transfer.
Show more...Investment focus
- Industry: Medical, mHealth, Diabetes
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- D-EYE — D-EYE's technology enables healthcare professionals all over the world to quickly screen for problems, photograph them and then distribute them digitally via various secure wireless solutions. They design and manufacture diagnostic instruments.
Sviluppo Imprese Centro Italia is an independent asset management company founded in Florence in 1998. Active in the Private Equity and Venture Capital sector, it currently manages four closed-end funds for a total value of around 140 million euro and has already carried out numerous operations. in the capital of companies operating in variousindustrial sectors, from the most traditional to high-tech. The mission of SICI is to encourage the development of unlisted SMEs in Central Italy through the contribution of financial resources intended to strengthen their capital and financial structure. SICI intends to represent a Growth Partner for the investee companies and a strategic operator in the creation of value for the territory with an impact on the economic and social fabric in terms of competitiveness of the economic system, employment, entrepreneurial and managerial culture. Business Development Central Italy is an independent Italian managing closed-end funds company. Established in Florence in 1998, SICI has 4 Private Equity and Venture funds under management with a total committed capital of 140m Euros.
Show more...Investment focus
- Industry: Software, Travel, Medical
- Stage:Seed, Angel, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 6
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Cents — Cents is a platform that allows businesses to raise awareness in the market by supporting social and environmental causes.
- Parking My Car — Parking My Car offers transportation services.
- Recuperiamo srl — Recuperiamo srl is a food industry founded to prevent and reduce waste throughout the food chain. They are involved in the food industry through the Regusto brand. They can use geolocation to report on last-minute offers for their dishes.
Medical Device VC funding in Italy at a glance
Stats across 86 deals from 98 investors.
Access all 98 VC funds in Italy Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 98 VC funds investing in Italy Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!